Crystal Structure of the Interleukin-4/Receptor α Chain Complex Reveals a Mosaic Binding Interface  by Hage, Thorsten et al.
Cell, Vol. 97, 271±281, April 16, 1999, Copyright 1999 by Cell Press
Crystal Structure of the Interleukin-4/Receptor a
Chain Complex Reveals a Mosaic Binding Interface
with IL-4Ra only, which accounts for the nearly complete
IL-4 binding affinity. Subsequently, the intermediate
complex recruits the common g chain (gc) to form a
Thorsten Hage,* Walter Sebald,*³
and Peter Reinemer²
* Institut fuÈ r Physiologische Chemie II
signaling heterodimer (Kondo et al., 1993; Russell etTheodor-Boveri-Institut fuÈ r Biowissen Schaften
al., 1993). IL-4Ra has also been demonstrated to be a(Biozentrum)
component of the IL-13 receptor, and in certain cellUniversitaÈ t WuÈ rzburg
types the intermediate complex can also recruit the IL-Am Hubland
13Ra1 receptor chain (Callard et al., 1996; Obiri et al.,D-97074 WuÈ rzburg
1997). In response to IL-4 (and IL-13), the importantGermany
intracellular signaling proteins STAT-6 and IRS1/2 are²Bayer AG
activated after association with the a chain (Hou et al.,Pharmaforschung (PH-R LSC-NP)
1994). Human IL-4 mutant proteins modified in gc/IL-Postfach 101709
13Ra1 binding retain high-affinity binding to IL-4Ra andD-42096 Wuppertal
act as selective/partial agonists or as IL-4 antagonistsGermany
(Kruse et al., 1992; Shanafelt et al., 1998).
The separately expressed 207-residue ectodomain of
the a chain (IL4-BP) forms a 1:1 complex with IL-4 andSummary
exhibits the same binding affinity as the entire receptor
a chain (Hoffman et al., 1995; Shen et al., 1996). ItsInterleukin-4 (IL-4) is a principal regulatory cytokine
primary structure reveals features of a cytokine recep-during an immune response and a crucial determinant
tor homology domain (CHR) and exhibits maximal se-for allergy and asthma. IL-4 binds with high affinity
quence similarity with ectodomains of type I cytokineand specificity to the ectodomain of the IL-4 receptor
receptors that interact with short chain or long chaina chain (IL4-BP). Subsequently, this intermediate com-
helical cytokines and form homodimeric or heterodi-plex recruits the common g chain (gc), thereby initiat-
meric receptors in the membrane (Bazan, 1990).ing transmembrane signaling. The crystal structure of
The structure of receptor-unbound human IL-4 hasthe intermediate complex between human IL-4 and
been described in crystals and in solution (Powers etIL4-BP was determined at 2.3 AÊ resolution. It reveals
al., 1992; Smith et al., 1992; Walter et al., 1992; Wlodawera novel spatial orientation of the two proteins, a small
et al., 1992). It resembles structures of other short chainbut unexpected conformational change in the recep-
four-helix bundle cytokines (Sprang and Bazan, 1993)tor-bound IL-4, and an interface with three separate
such as GM-CSF, IL-2, and IL-5 and exhibits the sameclusters of trans-interacting residues. Novel insights
helix topology and connectivity as the long chain four-on ligand binding in the cytokine receptor family and
helix bundle cytokines including hGH, EPO, IL-6, and
a paradigm for receptors of IL-2, IL-7, IL-9, and IL-15,
G-CSF (Sprang and Bazan, 1993; Rozwarski et al., 1994).
which all utilize gc, are provided. The functional epitope of IL-4 that determines the
high-affinity binding to the receptor a chain has been
located on the helix AC face (Kruse et al., 1993), andIntroduction
functional amino acid residues of IL-4 that determine
IL4-BP binding have been identified by mutational andBinding of interleukin-4 (IL-4) to its receptor a chain
quantitative interaction analysis (Wang et al., 1997). De-
(IL-4Ra) is a crucial event for the generation of a Th2-
spite these studies, mechanistic understanding of the
dominated early immune response (Seder and Paul, 1994;
IL-4 receptor system has been hampered by a lack of
Mosmann and Sad, 1996). The Th2-type cytokines, IL-4 structural information of receptor complexes.
itself as well as IL-5 and IL-13, recruit and activate IgE- We have previously developed methods to obtain hu-
producing B cells, eosinophils, and mast cells that tag, man IL4-BP from E. coli and have generated crystals of
attack, and expel parasites in mucosal tissues and in the 1:1 complex with human IL-4 (Hage et al., 1998). Here
the skin (Desreumaux and Capron, 1996; Finkelman et we describe the crystal structure, at 2.3 AÊ resolution, of
al., 1997). IL-4 and the same cellular triad exert a patho- this intermediate complex, which is obligatorily pro-
physiological role during allergic inflammations associ- duced during IL-4 receptor activation. This represents
ated with allergic asthma, rhinitis, conjunctivitis, and an experimentally determined structure of a receptor
dermatitis (Romagnani, 1994; Drazen et al., 1996). The complex in the short chain four-helix bundle cytokine
IL-4 receptor complex therefore represents a promising family and is likely the paradigm for the receptors of
target for immunotherapy of allergic diseases. IL-2, IL-7, IL-9, and IL-15, which all utilize the common
The cellular responses to IL-4 are mediated by assem- g chain (Sugamura et al., 1996). The structure reveals a
bling two different receptor chains in the plasma mem- novel spatial orientation of receptor and ligand, a small
brane. Receptor activation follows an ordered sequen- but unexpected conformational change in the receptor-
tial mechanism where solute IL-4 associates primarily bound ligand, and a binding interface consisting of three
separate clusters of trans-interacting residues. Together
with the mutational analysis, the structure provides³ To whom correspondence should be addressed (e-mail: sebald@
biozentrum.uni-wuerzburg.de). novel insights on ligand binding in the cytokine receptor
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Table 1. Crystallographic Analysis
Data Collection and Phasing Statisticsa
Phasing Powere
Data Wavelength Resolution Overall Unique Completeness f9 f99
Set (AÊ ) (AÊ ) I/s Reflections (%)b RMerge (%)c RAnom (%)d (e2) (e2) Acentric Centric
NATI 1.2 25±2.3 52.5 16,897 99.7 (99.2) 3.8 (6.7)
SML1 0.9761 20±2.3 21.3 16,959 97.9 (98.8) 3.8 (10.4) 2.38 (14,084) 26.4 8.0 0.77 (6,523) 0.56 (1,214)
SML2 0.9770 20±2.3 21.5 17,035 98.5 (99.8) 3.7 (10.1) 1.22 (14,264) 29.5 3.8 0.0 (6,529) 0.0 (1,231)
SML3 1.2 20±2.3 21.1 17,129 98.9 (99.9) 4.2 (13.1) 1.24 (14,077) 21.5 1.1 1.01 (6,521) 0.64 (1,224)
Refinement Statisticsf
Rms Deviations Model Atoms Average B Factor (AÊ b±h)
Resolution (AÊ ) R Factorg (%) Rfreeg (%) Bond (AÊ ) Angles (8) Protein Water Protein Water
25.0±2.3 21.8 (28.4) 28.9 (34.4) 0.012 1.7 2,565 230 20.5 30.0
a Phases were calculated using data from 13.0 to 3.0 AÊ resolution; overall figure of merit (FOM: |S P(a)exp(ia)/S P(a)| where a is the phase
and P(a) is the phase distribution probability) was 0.51. Thirty cycles of density modification increased FOM to 0.77 and dropped Rfree from
0.59 to 0.39.
b Values in parentheses for last resolution shell (2.4 to 2.3 AÊ ).
c RMerge 5 100 3 Sh,i |I(h)i 2 ,I(h)i .|/Sh,i I(h)i for the intensity I of i reflections of h. ,I(h). is the mean intensity of the reflection. Bijvoet mates
are treated independently. Values in parentheses for last resolution shell (2.4 to 2.3 AÊ ).
d RAnom 5 100 3 Sh |F(h)1 2 F(h)2|/Sh |F(h) 1 F(h)2| for the amplitudes F(h)1 and F(h)2 of corresponding Friedel pairs; number of unique reflections
with Friedel pairs in parentheses.
e Mean heavy atom contribution over lack of closure: S |FHc|/S ||FPHo| 2 ||FPo| exp(iac) 1 Fhc||; FHc is the calculated heavy atom structure
factor, |FHc| the corresponding amplitude, |Fpo| and |FPHo| the observed amplitudes for the protein and heavy atom derivatives, and ac the
calculated phase; number of phased reflections in parentheses.
f Statistics for data with F . 3s. A total of 16,652 unique reflections from 25.0 to 2.3 AÊ was used; the working set comprised 15,855 reflections
(93.5% overall completeness, 92.4% completeness in last resolution shell from 2.4 to 2.3 AÊ ); the test set comprised 797 reflections (4.7%
overall completeness, 3.7% completeness in last resolution shell from 2.4 to 2.3 AÊ ). A solvent mask generated in X-PLOR was included in all
R factor calculations.
g R factor 5 100 3 S |Fobs 2 Fcalc|/S |Fobs|; Fobs and Fcalc are the observed and calculated structure factor amplitudes. Rfree, like R factor but
calculated from 5% of the reflection data that were excluded from refinement. Values in parentheses for last resolution shell (2.35 to 2.3 AÊ ).
h A restrained B factor model as implemented in X-PLOR was used; rms deviation in B factors for bonded atoms is 1.7 AÊ 2.
family and may also be helpful for the design of IL-4 that are engaged in three disulfide bridges, namely Cys-
9±Cys-19, Cys-49±Cys-61, and Cys-29±Cys-59 (Figurereceptor a chain blockers with therapeutic potential for
both IL-4- and IL-13-mediated allergic diseases. 1B). The first two have been postulated to be conserved
among class I CHR's (Bazan, 1990), while the latter is
unique to IL4-BP. D2 exhibits standard FN III±like topol-Results and Discussion
ogy (s type) (Bork et al., 1994) with two additional short
310 helices and no disulfide bridges (Figure 1B). TheStructure of the IL-4/IL4-BP Complex
We solved the structure of the IL-4/IL4-BP complex by conserved ªWSXWSº motif (Bazan, 1990) implicated in
folding and transport of the receptor (Livnah et al., 1996)multiwavelength anomalous diffraction (MAD) using a
selenomethionine-labeled IL-4 mutant (Table 1; see Ex- comprises residues 187±191 (sequence WSEWS) and is
situated in a b bulge preceding strand G. Both indoleperimental Procedures). The model was refined to 2.3
AÊ resolution and exhibits Rfree and Rcryst values of 28.9% rings are oriented toward the neighboring strand F and
are intercalated between the guanidinium groups of Arg-and 21.8%, respectively, and comprises the entire 129
residues of IL-4 and 188 out of 207 residues of IL4-BP. 175 and Arg-177 of strand F, leading to a stack of four
parallel p systems at 4 AÊ spacings.Residues 108±111, 164±168, and 198±207, which are
located in membrane-proximal loops, were disordered The structure of IL-4 in complex with IL4-BP is very
similar to that of free IL-4. However, from the experimen-in the crystal and excluded from structure analysis.
IL4-BP exhibits an overall L shape and is organized tal electron density map, it was evident that in com-
plexed IL-4 the relative orientation of helices is alteredin two covalently linked domains, D1 (residues 1±91)
and D2 (residues 97±197). The domains are related in (Figure 2), since models of free IL-4 (PDB entries 1rcb
[Wlodawer et al., 1992] and 1int [Walter et al., 1992]) didoverall topology to fibronectin type III (FN III) modules
(Bork et al., 1994) and fold into a sandwich comprising not fit. A comparison of the overall structures of unbound
and complexed IL-4 (using residues 4±124) revealed rmsseven antiparallel b sheets arranged in three-strand
(strands designated A, B, E) and four-strand (G, F, C, deviations between equivalent Ca positions of about 0.8
AÊ . Even if less-well-defined areas (both long overhandC9) b-pleated sheets that are twisted against each other
by z408 (Figure 1A). D1 belongs to the h-type topological loops) that show significant alteration are excluded from
the calculations, observed rms deviations remain signifi-subclass of the immunoglobulin fold (Bork et al., 1994)
where strand C9 interacts first with strand C, and then cant. A four-helix bundle fit (using residues 5±17, 42±59,
70±94, and 109±125) yielded rms of about 0.63 AÊ forits direct continuation (now designated D) switches to
interact with strand E. It contains an additional single the pair-complexed IL-4 versus free IL-4 compared to
approximately 0.26 AÊ for the pairs 1rcb versus 1int andhelical turn in the BC loop and six cysteine residues
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Figure 1. Structure of the IL-4/IL4-BP Complex
(A) A stereoribbon view of the complex (IL4-BP, blue/yellow; IL-4, red). Helices and strands are labeled according to Bork et al. (1994), and
NH2 and COOH termini are labeled N and C, respectively. The five IL4-BP loops that interact with IL-4 are highlighted in yellow and labeled
according to deVos et al. (1992). They are oriented in a stack-like fashion comprising four levels with the sequence L2, L3, L1, and L5 and
L6 if listed from top to bottom. L4, which is depicted in blue, connects D1±D2 and has no interactions with IL-4 but is included for consistency.
(B) Topological diagram of the domains of IL4-BP. Domain D1 (residues 1±91) consists of an h-type fold and domain D2 (residues 97±197) of
an s-type fold. Secondary structure elements as calculated using the program DSSP (Kabsch and Sander, 1983) are depicted as arrows
(b strands) and boxes (a/310 helices). The positions of the six cysteine residues engaged in disulfide bridges (Cys-9±Cys-19, Cys-29±Cys-59,
Cys-49±Cys-61) are marked in blue bars. The location of the conserved WSXWS motif in D2 preceding bG is also indicated, and the five
recognition loops of IL4-BP with IL-4 are drawn in red and labeled L1±L3 and L5±L6; the noninteracting loop L4 is depicted in black.
complexed IL-4 versus complexed SeMet-IL-4. Promi- functional importance for the formation of the signaling
receptor heterodimer, since it was observed that gcnent structural alterations occur on helices A and D of
IL-4 in the region of the putative gc-binding site (Let- does not bind solute IL-4 at sub-mM concentrations
(Letzelter et al., 1998). Accordingly, conformationalzelter et al., 1998) and are characterized by decreased
intramolecular Ca±Ca distances between the residue changes in IL-4 imposed by IL4-BP binding may en-
hance effective interaction of gc with the IL-4/IL4-BPpairs Ile-11±Tyr-124 and Asn-15±Tyr-124 by 1.0 and 1.5
AÊ , respectively. Structural changes involving residues complex. It should be noted, however, that helix D is
involved in intimate crystal contacts, which may alterna-of the IL4-BP-binding site (see below) are rather minute
and are characterized by a decrease of the intramolecu- tively be responsible for the observed structural alter-
ations of IL-4 in the complex crystals.lar Ca±Ca distances between the residues Arg-88 and
Thr-13 and Arg-53 in the range of 0.4 to 0.6 AÊ when The quaternary structure of the complex is assembled
by IL4-BP binding to the helix AC face of IL-4 and iscompared to identical intramolecular distances of free
IL-4. The observed conformational changes may be of characterized by an almost perpendicular orientation of
Cell
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Figure 2. Structure of Receptor-Bound IL-4
Ribbon representation illustrating conformational differences between free IL-4 (yellow, 1rcb [Wlodawer et al., 1992]; green, 1int [Walter et
al., 1992]) and IL-4 in complex with IL4-BP (red, wild-type IL-4; blue, SeMet-IL-4).
the L-shaped IL-4BP to the helical axes of aC and aA These two clusters may be compared with an ªavocado
fruit,º where a nucleus is also enveloped by an oily shell.of IL-4. Loops of IL4-BP that interact with IL-4 are almost
colinear with the axes of the IL-4 helices and are oriented Because polar interactionsÐboth hydrogen bonds and
ionic bondsÐare enhanced in a hydrophobic environ-in a stack-like fashion. They comprise four different lev-
els, namely loop L2 from IL4-BP interacting with helix ment, such a structure seems to be highly relevant for
binding.B of IL-4, loops L3 and L1 interacting with aC, and loops
L5 and L6 interacting with aA (Figure 1A). The first ªavocado clusterº is assembled around Glu-9
of IL-4 (Figure 4A) where the carboxylate accepts three
bonds from receptor Tyr-13, Tyr-183, and Ser-70. TheThe IL-4/IL4-BP Contact
The surface areas buried upon complex formation are geometrically perfect assembly seems to be preoriented
by an internal bond of the carboxylate to IL-4 Asn-89811 AÊ 2 on IL-4 and 835 AÊ 2 on the receptor and are similar
in size to those buried in the topologically equivalent and is further complemented by additional bonds linking
IL-4 Thr-6, Lys-12, Thr-13, and Asn-89 to receptor Ser-low-affinity contact between hGHbp and site II of hGH
(deVos et al., 1992). This indicates that a high-affinity 70, Tyr-183, Tyr-127, and Ala-71. In addition, a single
ordered water molecule, locked in the contact area, caninteraction (Kd z150 pM) can also be generated from a
likewise small contact area and that its size is not directly bridge receptor Tyr-127 and IL-4 Asn-89. This network
is encased by aliphatic and aromatic groups; IL-4 Glu-9related to binding affinity. Upon association, the acces-
sible surface of 18 residues of each contact partner is has van der Waals contacts with IL-4 residues Ile-5, Lys-
12, and Thr-13 and furthermore lays flat on the aromaticdecreased by 7 to 132 AÊ 2. In each protein, six residues
bury more than 80% of their surface, and contact areas ring of receptor Tyr-127 with the carboxylate encircled
by side chains of receptor Tyr-13, Tyr-183, Val-69, anddeviate markedly from planarity (Figure 3). It is important
to note the polar character of the interacting epitopes Ala-70. The second avocado cluster contains a central
salt pair linking IL-4 Arg-88 and receptor Asp-72 (Figurethat are highly discontinuous and comprise multiple se-
quence segments. Contact residues on IL-4 are distrib- 4B). The guanidino and carboxylate moieties are orien-
tated in plane and align edge to edge with two hydrogenuted over three helices and comprise mainly polar and
charged residues. The complementary receptor epitope bonds present. Asp-72 seems to be hardly accessible
in the free receptor, while the Arg-88 side chain is com-is assembled from residues of five loops and has a
midline of hydrophobic side chains with patches of tyro- pletely accessible in free IL-4. In the complex, it is bent
over receptor Val-69 and shielded from above by thesine and serine residues situated on one side and a
patch of aspartic acid side chains on the other side side chain of receptor Phe-41. The IL-4 side chains Arg-
53 and Trp-91 are packed against the edge of Phe-41,(Figures 1 and 3).
The binding epitope reveals a mosaic-like assembly and accordingly, the salt pair is embedded by hydropho-
bic side chains. Remarkably, Trp-91 and Arg-53 are ori-consisting of three discrete clusters of trans-interacting
residues. Two of them exhibit a conspicuous amphi- ented to bulk solvent in free IL-4 and both rearrange in
the contact. The third cluster of trans-interacting sidepathic structure with an outer mantle of hydrophobic
side chain moieties and an inner core of polar groups. chains has a completely different design dominated by
Structure of the IL-4/IL4-BP Complex
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Figure 3. The Structural Epitope of the IL-4/IL4-BP Complex
(A) Decrease in solvent accessibility on complex formation for IL-4 (top) and IL4-BP (bottom) and loss of binding free energy upon alanine or
glutamine substitution for IL-4 (taken from Wang et al., 1997). Solvent accessibility was calculated with the program DSSP (Kabsch and
Sander, 1983); a probe radius of 1.4 AÊ was used. The solvent-accessible surface area of Tyr-13 does not change upon IL-4 binding; it forms,
however, a hydrogen bond with IL-4 Glu-9. Residues of IL-4 are color coded according to the loss in binding free energy: red . 3.5 kcal/mol,
blue 0.5±1.5 kcal/mol, green 0.3±0.5 kcal/mol. Substitution of IL-4 Lys-12 does not result in a significant loss in binding free energy. Mutant
data for IL-4 Tyr-56 and Ser-57 and for IL4-BP are not yet available.
(B) Open-book view of the complementary structural epitopes on IL-4 (left) and IL4-BP (right). Contact residues are colored according to their
physicochemical properties (red, negatively charged [Asp, Glu]; dark blue, positively charged [Arg, Lys]; light blue, histidine; cyan, glutamine/
asparagine; magenta, tyrosine; orange, serine/threonine; and green, hydrophobic).
electrostatic interactions (Figure 4C). IL-4 residues Arg- geometry deviates significantly from standard sp2-type
donor±acceptor interaction. Thus, cluster III has no func-81, Arg-85, Gln-78 and receptor Asp-66, Asp-67, Asp-
125 cannot establish strong hydrogen bonds, since their tion in stabilizing the complex and seems to participate
Cell
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Figure 4. Details of the IL-4/IL4-BP Contact
(A) The IL-4 Glu-9 forms the center of a global hydrogen network and is encased by hydrophobic side chains (ªavocadoº cluster I, see text).
(B) The IL-4 Arg-88 receptor±Asp-72 ion pair is surrounded by aliphatic groups (ªavocadoº cluster II, see text).
(C) Electrostatic attractions dominate cluster III.
only in electrostatic steering to accelerate complex for- The previous results of a systematic mutational analy-
sis of IL-4 contact residues support the functional signif-mation. The complementary electrostatic potentials are
further accentuated by IL-4 Arg-53, Lys-77, and Trp-91 icance of the three clusters of trans-interacting residues
identified in the structure of the complex and confirmand by receptor Asp-72 and seem to cause the extraor-
dinary fast association rate constant (kon z107 M21s21) the existence of a mosaic binding (Wang et al., 1997).
Mutation of the central core residues of IL-4, namely(Demchuk et al., 1994). Mouse IL-4, which associates
twice as slowly to its receptor (Grunewald et al., 1997), Glu-9 in cluster I or Arg-88 in cluster II, resulted in a loss
in binding affinity by two to three orders of magnitude.has a large deletion in the N-terminal part of helix C and
lacks the basic residues in this segment. Mutation of peripheral residues, namely Asn-89, Ile-5,
Structure of the IL-4/IL4-BP Complex
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or Thr-13 in the shell of cluster I and Trp-91 or Arg-53 and IL-15, which all depend on gc for signaling (Suga-
mura et al., 1996). Particular interest may be attributedin the shell of cluster II, produced a loss in binding affinity
to the tripartite IL-2 receptor system comprising gc (alsoby less than one order of magnitude, in accordance with
called IL-2Rg) and IL-2Rb as signal transducer and IL-a more auxiliary role of the affected groups. Estimated
2Ra as affinity enhancer chains (Sugamura et al., 1996).from the loss of free binding energy in the affected mu-
The low-affinity gc-binding epitopes exist at the sametant proteins, cluster I and cluster II contribute to the
site on the helix AD face in IL-2 (Zurawski et al., 1993)same extent to binding. All mutations in cluster III side
and IL-4 (Kruse et al., 1993) and comprise similar bindingchains have only small effects on binding and solely on
residues in both interleukins (Letzelter et al., 1998). Simi-the association rate constants of the mutant proteins,
lar to the IL-4/IL4-BP interaction, IL-2 has been estab-thus confirming the likewise minor functional role of
lished to bind its specific IL-2Rb chain via the helix ACthese elements as already deduced from the structure.
face of IL-2 (Zurawski et al., 1993). However, a structuralIt is very likely that side chains in the same cluster co-
alignment of IL-2 and IL-4 reveals that structurally corre-operate and that the effects of individual substitutions
sponding positions of the main determinants of IL-2are therefore not always additive. Nevertheless, both
(e.g., Asp-20 in human IL-2) and IL-4 (e.g., Glu-9) arethe structural and functional analyses of the interface
situated in different helical turns of helix aA: IL-2 Asp-strongly suggest that the cluster I interactions are inde-
20 is shifted one helical turn toward the C terminus ofpendent of those in cluster II.
helix aA compared to IL-4 Glu-9 (Bamborough et al.,The mosaic design of the binding epitope opens a
1994; Rozwarski et al., 1994; Gustchina et al., 1995).perspective for structure-based drug design: a low-
This suggests that IL-2Rb may bind IL-2 in a slightlymolecular-weight compound mimicking one of these
displaced position, shifting the epitope closer to theclusters may bind to IL4-BP with a significant and mea-
AB loop, the established binding epitope for IL-2Ra.surable affinity. Since both clusters seem to bind inde-
Thereby, IL-2Rb may be able to interact with IL-2Ra,pendently, it may be possible to find mimics for each
which is a prerequisite for the observed transition fromcluster separately. Subsequently, the individual mimics
medium to high affinity in the human IL-2 receptor sys-may be linked to yield a greatly increased binding affinity
tem (Sugamura et al., 1996).of the composite. A similar approach based on SAR by
NMR has been proposed before (Shuker et al., 1996).
Structural Comparison of IL4-BP to Long Chain
Four-Helix Bundle Cytokine ReceptorsThe Putative gc-Binding Site and Implications
A structure-based sequence alignment, based on pair-for Other gc-Dependent Cytokine
wise structural superposition of separated domains (Fig-Receptor Systems
ure 5A), reveals conserved core structures comprisingInteraction analysis of the binding of the gc ectodomain
the b sheets, the WSXWS motif, and the D1±D2 linker,to IL-4 or the IL-4/IL4-BP complex revealed that the
which superimpose with good agreement. In contrast,interchain site III contact (Kd . 30 mM) contributes only large variations are found in fold and length of interactingmarginally to binding (Letzelter et al., 1998). This sup-
loops and in the type of employed contact residues. Theports the idea that, similar to the EBP/EMP-1 complex
D1±D2 connecting loop L4 is not used for ligand binding
(Livnah et al., 1996), the IL-4 receptor heterodimer has
in IL4-BP; L4 is also not used in the site 2 contacts of
no major interchain contacts. Mutational analysis has
hGHbp (deVos et al., 1992) and EBP (Syed et al., 1998)
identified IL-4 residues Ile-11, Asn-15, and Tyr-124 as but exhibits ligand contacts in their high-affinity site 1.
main determinants for gc ectodomain binding. The An entire CHR overlay for IL4-BP, hGHbp (deVos et
structure shows that these side chains assemble a linear al., 1992), EBP (Livnah et al., 1996), and gp130 (Bravo
epitope juxtaposed to the IL-4/IL4-BP contact. It is ori- et al., 1998) based on a pairwise superposition calcu-
ented perpendicular to the long axis of IL4-BP and ex- lated for domains D2 reveals strikingly different orienta-
tends parallel to the Glu-9 to Arg-88 motif in the IL4-BP tions for their domains D1: if viewed from the ligand,
contact. The site II low-affinity epitope of IL-4 tolerates IL4-BP-D1 has to be rotated by z458 using Ser-70 Ca
substitutions by hydrophobic residues with only minor as a pivot to approximately fit hGHbp/EBP-D1. A com-
effects on gc binding affinity (Letzelter et al., 1998). Se- pletely different domain orientation is adopted by gp130.
quence alignment and model building studies (Bambor- However, despite deviating courses for the loops L1,
ough et al., 1994; Gustchina et al., 1995) of gc suggest L2, and L3, some contact residues colocalize.
a largely hydrophobic residue composition of the loops A structural comparison of residues employed in bind-
L1, L4, and L5, which putatively may interact with the ing loops may hint to their relative functional importance:
functional residues in IL-4 site II. Partial and selective direct structural homologs of IL4-BP Tyr-127 (L5) are
agonistic as well as antagonistic variants of human and Trp-169 in hGHbp, Met-150 in EBP, and Val-230 in
mouse IL-4 have been generated (Kruse et al., 1992; gp130. Trp-169 and Trp-104 of hGHbp have been identi-
Shanafelt et al., 1998) by substitution of Asp or Glu for fied as mutational hot spots in the hGH/(hGHbp)2 com-
the functional residues Ile-11, Asn-15, Tyr-124 or for plex (Clackson and Wells, 1995), and substitutions of
Arg-121 and Ser-125. Most likely, these substitutions EBP Met-150 (Middleton et al., 1996) and gp130 Val-230
cause a mismatch with negatively charged side chains (Horsten et al., 1997) are characterized by a dramatic
in gc or IL-13Ra1. Possible candidates exist in the L2 loss of binding activity. In contrast, the structural model
loop (sequence NSDND) of human gc, whereas in the of IL4-BP suggests that Tyr-127 is probably not a main
ternary complex, L2 could interact with IL-4 Arg-121. determinant for binding, since it is only a peripheral
The interaction of IL-4 and IL4-BP possibly represents component of the hydrophobic shell of cluster II. Asp-
72 of IL4-BP (L3) is the core element in cluster II and isa paradigm for the receptor systems of IL-2, IL-7, IL-9,
Cell
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Figure 5. Conservation and Variation in Cytokine Receptor Binding
(A) Structure-based sequence alignment of different extracellular domains of cytokine receptors IL4-BP (human interleukin-4-binding protein),
hGHbp (human growth hormone±binding protein), EBP (human erythropoietin-binding protein), and gp130. Pairwise structural superposition
for isolated receptor domains as indicated by D1 and D2 (IL4-BP, this work; hGHbp, site II contact, PDB entry 3hhr [deVos et al., 1992]; EBP,
PDB entry 1ebp [Livnah et al., 1996]; and gp130, PDB entry 1bqu [Bravo et al., 1998]) were calculated using BRAGI. Amino acid sequences
are given in one letter code; deletions are marked ª-º; sequence numbering (ruler) and secondary structure designation (structure) are given
for IL4-BP. Individual secondary structure elements as calculated with DSSP are depicted by black (b strands) and red (a/310 helices) boxes.
A blue background indicates structural superposition with a Ca±Ca distance # 1.8 AÊ . Rms deviations for IL4-BP domain D1 with hGHbp D1,
EBP D1, and gp130 D1 are 1.05, 1.08, and 1.11 AÊ with 45, 66, and 53 matching Ca pairs with a Ca±Ca distance # 1.8 AÊ . For IL4-BP D2,
hGHbp D2, EBP D2, and gp130 D2, corresponding rms deviations are 1.01, 0.89, and 0.93 AÊ with 71, 75, and 66 matching pairs.
(B) Overlay of the IL-4/IL4-BP complex (blue) and the hGH/hGHbp2 complex (red) based on a superposition of the ligands (Rozwarski et al.,
1994). It reveals that IL4-BP is rotated by 308 toward helix B compared to hGHbp with an axis approximately passing through the aligned
loops L3. Despite this remarkably altered relative position, the orientation of D1 and D2 seems to follow the angle between helices A and C
of the ligand: each domain D1 is oriented nearly perpendicular to helix C, and each domain D2 aligns approximately perpendicular to helix
A in each cytokine. The low-affinity site II contact in the hGH receptor exhibits fragments of binding clusters of the high-affinity IL-4 receptor:
hGH Asn-12 aligns with receptor Trp-169 and might form a hydrogen bond to Arg-43, similar to IL-4 Glu-9 contacting receptor Tyr-127 and
being hydrogen bonded to Tyr-13. Apparently, only a weak interaction exists in hGH, and not surprisingly, an Asn-12 to Ala mutation has no
discernible effect (Cunningham et al., 1991). A remarkable reorientation of side chains involves Trp-104, which contacts Gly-120. The corre-
sponding interaction in IL-4/IL4-BP is Tyr-127, which contacts via a water molecule IL-4 Asn-89. The prominent site II determinants of hGH
(Phe-1 and Ile-4) have no functional equivalent side chains in IL-4. Thus, both the spatial orientation of IL-4 and IL4-BP in the complex and
the functional and structural properties of the contact reveal novel features different from the binding in the homodimeric hGH receptor complex.
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Experimental Proceduresinvolved in tight interactions with IL-4 Glu-88. It resem-
bles Trp-104 of hGHbp and Phe-93 of EBP, which are
Protein Purification and Complex Formationof predominant functional importance, and seems to be
The 207-residue ectodomain of the IL-4 receptor a chain (IL4-BP)
a major binding determinant. Comparison of loops L1 was produced as described (Hage et al., 1998). Briefly, a M1F/
and L6 reveal a number of differences: Tyr-13 (L1) and C182A mutant of IL4-BP was expressed in E. coli, extracted from
the insoluble fraction, refolded, and purified using an IL-4 affinityTyr-183 (L6) of IL4-BP are major components of cluster I
column. For structure solution, a selenomethionine-labeled M0A/that are engaged in intimate interactions with IL-4 Glu-9.
T25M/L27M/Y124M mutant of IL-4 (SeMet-IL-4) was produced byThe equivalent of Tyr-13 is Arg-43 of hGHbp, which is
expression in a methionine auxotrophic E. coli strain. SeMet-IL-4less important only in terms of binding free energy. Tyr-
and native human IL-4 were purified as described (Kruse et al.,
183 has no homolog in hGHbp and EBP. Nevertheless, 1992). Complexes were formed using a 1:1.2 molar ratio of IL4-BP
both tyrosine residues seem to be major binding deter- and SeMet-IL-4 and IL-4, respectively, and were subjected to size
exclusion chromatography prior to crystallization.minants, and mutational analysis by alanine scanning
supports the relative importance of IL4-BP residues Tyr-
Crystallization and Data Collection13, Asp-72, and Tyr-183 for specific ligand binding (un-
Crystals were grown at room temperature by vapor diffusion inpublished data). The binding function of hydrophobic
hanging drops containing equal volumes of 10 mg ml21 complex (inloop L2 (comprising Leu-39, Phe-41, Leu-42, and Leu-
25 mM sodium acetate [pH 5.0], 120 mM NaCl) and reservoir solution
43) that contributes to the hydrophobic shell in cluster [20% (v/v) ethanol, 5% (v/v) methylpentanediol, 100 mM Tris/HCl
II is unique to the IL-4/IL4-BP receptor complex. {pH 8.0}). Crystals contain one complex molecule in the asymmetric
The intermediate IL-4/IL4-BP complex differs from unit and belong to space group P212121. X-ray diffraction data were
collected at beamline BW-6 at the MPG outstation at DESY, Ham-other structurally characterized cytokine receptors, since
burg using a MAR345 imaging plate detector. Crystals were cryopro-its high-affinity contact is provided by the helix AC face
tected in artificial mother liquor containing 20% (v/v) ethanol, 25%of the ligand. A comparison with the topologically equiv-
(v/v) glycerol, 100 mM Tris/HCl (pH 8.0) before cooling to 100 K.
alent low-affinity complex of hGHbp and site II of hGH MAD data were collected at three wavelengths around the K sele-
(deVos et al., 1992) based on a superposition of the nium edge from a single crystal of the SeMet-IL-4/IL4-BP complex
ligands is depicted in Figure 5B. It indicates that struc- (cell constants a 5 50.39, b 5 68.34, c 5 108.59 AÊ ); native data
were collected from a single crystal of the IL-4/IL4-BP complex (a 5tural conservation of strategic Ca positions seems to be
49.72, b 5 67.98, c 5 108.46 AÊ ). Data sets were processed usingrelated to conserved structural elements in the ligand.
DENZO/SCALEPACK (Otwinowski and Minor, 1997) or MOSFLM/Despite their remarkably altered relative positions, the
ROTAVATA/AGROVATA (CCP4, 1994) (Table 1).
orientation of D1 and D2 seems to follow the angle be-
tween helices A and C of the ligand. Interestingly, the Structure Determination
low-affinity site II contact in the hGH receptor exhibits Vector verification as implemented in PROTEIN (Steigemann, 1991)
fragments of binding clusters of the high-affinity IL-4 was used to interpret an anomalous Patterson calculated from SML1
(peak wavelength) and yielded four selenium positions. All reflectionreceptor, although only weak interactions are formed.
data were scaled to SML3 (remote wavelength), and MAD data wereThus, both the spatial orientation of IL-4 and IL4-BP in
treated as a special case of MIR using SML2 (edge wavelength) asthe complex and the functional and structural properties
the ªnativeº and SML1 and SML3 as ªderivatives.º Initial phases for
of the contact reveal novel features different from the the SeMet-IL-4/IL4-BP complex were calculated with MLPHARE
binding in the homodimeric hGH receptor complex. (CCP4, 1994) using data from 13.0 to 3.0 AÊ resolution. They were
further improved by solvent flattening and histogram matching with
the program DM (CCP4, 1994). The obtained electron density mapIL-4Ra in IL-13 Signaling
at 3.0 AÊ resolution was of good quality and could be traced unambig-In many cells, the intermediate IL-4/IL-4Ra complex be-
uously.
comes transactivated by association with IL-13Ra1 (Cal-
lard et al., 1996; Obiri et al., 1997). This type 2 IL-4
Model Building and Refinement
receptor represents a challenging problem, since the A model for the SeMet-IL-4/IL4-BP complex comprising 87% of the
same heterodimer is formed with IL-13 as ligand. IL- 337 residues was built with the program O (Jones et al., 1991). The
model was subjected to a single round of crystallographic refine-13 has been recently identified as central mediator in
ment against SML3 using X-PLOR (BruÈ nger, 1992). Prior to refine-allergic asthma (GruÈ nig et al., 1998; Will-Karp et al.,
ment, a random set of 5% of the reflection data was sequestered1998). Remarkably, the interaction of IL-13 with the two
and used to monitor the free R value. The R factor was dropped toreceptor chains is reciprocal to that of IL-4. The specific
0.319 (Rfree 0.391) and the model was used to phase the native IL-high-affinity chain for IL-13 is IL-13Ra1, whereas the 4/IL4-BP complex. Subsequently, the native structure was refined
interaction between IL-13 and IL-4Ra seems to be of to 2.3 AÊ resolution against the native data using X-PLOR. Again, a
random set of 5% of the reflection data was excluded from refine-low affinity and could be observed only in the presence
ment and used for cross validation. Alternate cycles of refinementof the specificity chain. Thus, IL-4Ra has a high-affinity
and model building, accompanied by the addition of water mole-epitope for IL-4 and a low-affinity epitope for IL-13. The
cules, and inclusion of a solvent mask resulted in a final model withepitopes for the two ligands overlap or even coincide,
R 5 21.8% (Rfree 5 28.9%, 25.0±2.3 AÊ resolution). The final modelsince IL-4- as well as IL-13-dependent responses can was analyzed with PROCHECK (Laskowski et al., 1993), exhibited
be inhibited by antagonistic IL-4 variants acting as IL- good stereochemistry, and had 87.1% of the residues in the most
favored regions of a Ramachandran plot, 11.5% of the residues in4Ra chain blockers (Tony et al., 1994). The existence of
the additional allowed regions, 1.4% in generously allowed regions,a promiscuous binding epitope in IL-4Ra is reminiscent
and no nonglycine residues in disallowed regions.to the binding in the homodimeric growth hormone re-
Structural comparisons were done with the program BRAGIceptor complex where two identical receptor chains can
(Schomburg and Reichelt, 1988) and secondary structure assess-
bind via the same epitope either with high affinity to ments with DSSP (Kabsch and Sander, 1983). Figures were pro-
site 1 or with low affinity to site 2 of one hGH ligand duced with RIBBONS (Carson, 1991) or with MOLSCRIPT (Kraulis,
1991) and RASTER3D (Merrit and Murphy, 1994).(Cunningham et al., 1991).
Cell
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